SWOG clinical trial number
S0327

A Phase II Trial of PS-341 (NSC-681239) in Patients with Platinum-Treated Extensive Stage Small Cell Lung Cancer.

75% Accrual
Accrual
75%
Closed
Phase
75% Accrual
Accrual
75%
Published
Abbreviated Title
PS-341/Platinum-treated/Extensive SCLC
Activated
09/01/2003
Closed
09/15/2004
Participants
NCORP, Members, Medical Oncologists

Research committees

Lung Cancer

Treatment

Bortezomib

Other Clinical Trials

S2414
SWOG Clinical Trial Number

INcorporating pathologic reSponse in patIents with early staGe lung cancer to optimize immunotHerapy in the adjuvanT setting (INSIGHT)

Research Committee(s)
Lung Cancer
Symptom Control and Quality of Life
Activated
03/14/2025
1% Accrual
Accrual
1%
Open
Phase
A082002
SWOG Clinical Trial Number

A Randomized Phase II/III Trial of Modern Immunotherapy Based Systemic Therapy with or Without SBRT for PD-L1-Negative, Advanced Non-Small Cell Lung Cancer

Research Committee(s)
Lung Cancer
Activated
12/21/2021
Open
Phase
CTSU/NRG-LU007
SWOG Clinical Trial Number

RAndomized Phase II/III Trial Of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial

Research Committee(s)
Lung Cancer
Activated
08/17/2020
Open